skip to main content

S. 1140: Protecting Access to Biosimilars Act of 2019

Call or Write Congress

A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.

The bill’s titles are written by its sponsor.

Sponsor and status

Tina Smith

Sponsor. Junior Senator for Minnesota. Democrat.

Read Text »
Last Updated: Apr 11, 2019
Length: 3 pages
Introduced
Apr 11, 2019
Status

Introduced on Apr 11, 2019

This bill is in the first stage of the legislative process. It was introduced into Congress on April 11, 2019. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Prognosis
4% chance of being enacted according to Skopos Labs (details)
Source

History

Apr 11, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

If this bill has further action, the following steps may occur next:
 
Passed Committee

 
Passed Senate

 
Passed House

 
Signed by the President

S. 1140 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 1140 — 116th Congress: Protecting Access to Biosimilars Act of 2019.” www.GovTrack.us. 2019. June 16, 2019 <https://www.govtrack.us/congress/bills/116/s1140>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.